Logo image of HLMN

HILLMAN SOLUTIONS CORP (HLMN) Stock Fundamental Analysis

USA - NASDAQ:HLMN - US4316361090 - Common Stock

9.8155 USD
+0.08 (+0.78%)
Last: 9/17/2025, 12:29:53 PM
Fundamental Rating

3

HLMN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 128 industry peers in the Machinery industry. HLMN may be in some trouble as it scores bad on both profitability and health. HLMN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year HLMN was profitable.
In the past year HLMN had a positive cash flow from operations.
In the past 5 years HLMN reported 4 times negative net income.
Of the past 5 years HLMN 4 years had a positive operating cash flow.
HLMN Yearly Net Income VS EBIT VS OCF VS FCFHLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.92%, HLMN is doing worse than 67.19% of the companies in the same industry.
HLMN has a Return On Equity of 1.80%. This is in the lower half of the industry: HLMN underperforms 66.41% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.88%, HLMN is doing worse than 66.41% of the companies in the same industry.
HLMN had an Average Return On Invested Capital over the past 3 years of 1.94%. This is significantly below the industry average of 10.02%.
The last Return On Invested Capital (2.88%) for HLMN is above the 3 year average (1.94%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.92%
ROE 1.8%
ROIC 2.88%
ROA(3y)-0.11%
ROA(5y)-0.56%
ROE(3y)-0.26%
ROE(5y)-2.17%
ROIC(3y)1.94%
ROIC(5y)1.62%
HLMN Yearly ROA, ROE, ROICHLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

The Profit Margin of HLMN (1.44%) is worse than 64.06% of its industry peers.
HLMN's Operating Margin of 6.13% is on the low side compared to the rest of the industry. HLMN is outperformed by 60.16% of its industry peers.
In the last couple of years the Operating Margin of HLMN has grown nicely.
HLMN's Gross Margin of 47.80% is amongst the best of the industry. HLMN outperforms 90.63% of its industry peers.
HLMN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.13%
PM (TTM) 1.44%
GM 47.8%
OM growth 3Y102.86%
OM growth 5Y36.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y2.32%
HLMN Yearly Profit, Operating, Gross MarginsHLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

HLMN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HLMN has more shares outstanding than it did 1 year ago.
HLMN has more shares outstanding than it did 5 years ago.
HLMN has a better debt/assets ratio than last year.
HLMN Yearly Shares OutstandingHLMN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
HLMN Yearly Total Debt VS Total AssetsHLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

HLMN has an Altman-Z score of 1.83. This is not the best score and indicates that HLMN is in the grey zone with still only limited risk for bankruptcy at the moment.
HLMN's Altman-Z score of 1.83 is on the low side compared to the rest of the industry. HLMN is outperformed by 69.53% of its industry peers.
The Debt to FCF ratio of HLMN is 9.74, which is on the high side as it means it would take HLMN, 9.74 years of fcf income to pay off all of its debts.
HLMN has a worse Debt to FCF ratio (9.74) than 60.16% of its industry peers.
HLMN has a Debt/Equity ratio of 0.57. This is a neutral value indicating HLMN is somewhat dependend on debt financing.
HLMN's Debt to Equity ratio of 0.57 is in line compared to the rest of the industry. HLMN outperforms 40.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 9.74
Altman-Z 1.83
ROIC/WACC0.31
WACC9.3%
HLMN Yearly LT Debt VS Equity VS FCFHLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 2.28 indicates that HLMN has no problem at all paying its short term obligations.
The Current ratio of HLMN (2.28) is comparable to the rest of the industry.
HLMN has a Quick Ratio of 2.28. This is a bad value and indicates that HLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.72, HLMN is not doing good in the industry: 82.03% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 0.72
HLMN Yearly Current Assets VS Current LiabilitesHLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

HLMN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.77%, which is quite good.
HLMN shows a small growth in Revenue. In the last year, the Revenue has grown by 1.93%.
Measured over the past years, HLMN shows a small growth in Revenue. The Revenue has been growing by 3.93% on average per year.
EPS 1Y (TTM)12.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.25%
Revenue 1Y (TTM)1.93%
Revenue growth 3Y1.08%
Revenue growth 5Y3.93%
Sales Q2Q%6.16%

3.2 Future

HLMN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.84% yearly.
Based on estimates for the next years, HLMN will show a small growth in Revenue. The Revenue will grow by 5.08% on average per year.
EPS Next Y12.35%
EPS Next 2Y8.35%
EPS Next 3Y10.26%
EPS Next 5Y16.84%
Revenue Next Year5.85%
Revenue Next 2Y6.85%
Revenue Next 3Y5.98%
Revenue Next 5Y5.08%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HLMN Yearly Revenue VS EstimatesHLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
HLMN Yearly EPS VS EstimatesHLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.52 indicates a rather expensive valuation of HLMN.
Compared to the rest of the industry, the Price/Earnings ratio of HLMN indicates a somewhat cheap valuation: HLMN is cheaper than 72.66% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.20, HLMN is valued a bit cheaper.
HLMN is valuated correctly with a Price/Forward Earnings ratio of 16.08.
Based on the Price/Forward Earnings ratio, HLMN is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.71. HLMN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.52
Fwd PE 16.08
HLMN Price Earnings VS Forward Price EarningsHLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

71.09% of the companies in the same industry are more expensive than HLMN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLMN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 27.1
EV/EBITDA 11.3
HLMN Per share dataHLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

HLMN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.5
PEG (5Y)N/A
EPS Next 2Y8.35%
EPS Next 3Y10.26%

0

5. Dividend

5.1 Amount

HLMN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HILLMAN SOLUTIONS CORP

NASDAQ:HLMN (9/17/2025, 12:29:53 PM)

9.8155

+0.08 (+0.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners104.83%
Inst Owner Change-0.91%
Ins Owners1.13%
Ins Owner Change2.81%
Market Cap1.94B
Analysts81.43
Price Target12.56 (27.96%)
Short Float %2.96%
Short Ratio3.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.57%
Min EPS beat(2)1.2%
Max EPS beat(2)15.94%
EPS beat(4)2
Avg EPS beat(4)1.89%
Min EPS beat(4)-7.7%
Max EPS beat(4)15.94%
EPS beat(8)5
Avg EPS beat(8)5.14%
EPS beat(12)9
Avg EPS beat(12)33.05%
EPS beat(16)12
Avg EPS beat(16)285.05%
Revenue beat(2)1
Avg Revenue beat(2)0.1%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)1.61%
Revenue beat(4)1
Avg Revenue beat(4)-0.63%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)1.61%
Revenue beat(8)1
Avg Revenue beat(8)-1.53%
Revenue beat(12)1
Avg Revenue beat(12)-2.32%
Revenue beat(16)2
Avg Revenue beat(16)-1.92%
PT rev (1m)16.89%
PT rev (3m)14.92%
EPS NQ rev (1m)-2.19%
EPS NQ rev (3m)-14.29%
EPS NY rev (1m)3.9%
EPS NY rev (3m)3.9%
Revenue NQ rev (1m)-0.25%
Revenue NQ rev (3m)1.14%
Revenue NY rev (1m)1.27%
Revenue NY rev (3m)1.53%
Valuation
Industry RankSector Rank
PE 18.52
Fwd PE 16.08
P/S 1.29
P/FCF 27.1
P/OCF 12.52
P/B 1.61
P/tB N/A
EV/EBITDA 11.3
EPS(TTM)0.53
EY5.4%
EPS(NY)0.61
Fwd EY6.22%
FCF(TTM)0.36
FCFY3.69%
OCF(TTM)0.78
OCFY7.99%
SpS7.61
BVpS6.11
TBVpS-1.01
PEG (NY)1.5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.92%
ROE 1.8%
ROCE 4.43%
ROIC 2.88%
ROICexc 2.93%
ROICexgc 9.33%
OM 6.13%
PM (TTM) 1.44%
GM 47.8%
FCFM 4.76%
ROA(3y)-0.11%
ROA(5y)-0.56%
ROE(3y)-0.26%
ROE(5y)-2.17%
ROIC(3y)1.94%
ROIC(5y)1.62%
ROICexc(3y)1.97%
ROICexc(5y)1.64%
ROICexgc(3y)6.76%
ROICexgc(5y)6%
ROCE(3y)2.98%
ROCE(5y)2.49%
ROICexcg growth 3Y110.94%
ROICexcg growth 5Y37.21%
ROICexc growth 3Y112.78%
ROICexc growth 5Y43.98%
OM growth 3Y102.86%
OM growth 5Y36.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y2.32%
F-Score7
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 9.74
Debt/EBITDA 2.98
Cap/Depr 60.9%
Cap/Sales 5.54%
Interest Coverage 1.88
Cash Conversion 67.63%
Profit Quality 329.53%
Current Ratio 2.28
Quick Ratio 0.72
Altman-Z 1.83
F-Score7
WACC9.3%
ROIC/WACC0.31
Cap/Depr(3y)59.2%
Cap/Depr(5y)51.21%
Cap/Sales(3y)4.97%
Cap/Sales(5y)4.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.25%
EPS Next Y12.35%
EPS Next 2Y8.35%
EPS Next 3Y10.26%
EPS Next 5Y16.84%
Revenue 1Y (TTM)1.93%
Revenue growth 3Y1.08%
Revenue growth 5Y3.93%
Sales Q2Q%6.16%
Revenue Next Year5.85%
Revenue Next 2Y6.85%
Revenue Next 3Y5.98%
Revenue Next 5Y5.08%
EBIT growth 1Y6.16%
EBIT growth 3Y105.05%
EBIT growth 5Y41.6%
EBIT Next Year151.21%
EBIT Next 3Y40.11%
EBIT Next 5Y28.33%
FCF growth 1Y-49.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.36%
OCF growth 3YN/A
OCF growth 5Y28.46%